Tagged with Romania

Romania No one can accuse the Romanian government of being lethargic when it comes to healthcare reform. After an unprecedented seven years of zero new molecules being admitted to the state reimbursement list, the pharma industry has suddenly been subjected to a whirlwind of radical refashioning and legislatory upheaval. “The industry…

Romania Once touted by the IMS as one of the “fast followers” among the world’s “pharmerging” nations and feted by the international investor community in the wake of EU accession, Romania’s pharmaceutical industry appears resurgent once more after a number of years on the back burner. In 2014, Romania’s market size…

Romania Raed Arafat,  Secretary of State at the Romanian Ministry of Internal Affairs highlights the key trends in Romanian healthcare over recent years, his own role in reforming the country’s healthcare system, and the outlook for the future.   We still have lot of work to do and we need stability…

Romania The director of Romania’s national pharmaceuticals regulator outlines how his institution is embracing health technology assessment (HTA) capabilities and the transformative changes this will have on the local industry. He also speaks frankly about hot topics sweeping the sector: among them the pressing need for increased regulation of medical devices…

Romania The association’s longtime executive director outlines the opportunities and challenges for generics companies in the Romanian market. Analyzing in depth the local market regulatory landscape, he proposes modifications to the claw-back mechanism.   A non-governmental organization that aims to foster improved the access to affordable medicine for Romanian patients, The…

Zentiva The GM of one of the leading generics companies on the Romanian market shares insights into why generics penetration remains underdeveloped and the importance of having an export strategy and diversified portfolio.   You have been in your current position since 2009, witnessing many changes. Can you introduce Zentiva in…

National Agency for Medicines and Medical Devices (NAMMD) of Romania Under various former names for over five decades, the Agency has undoubtedly played a key role in setting a regulatory framework for Romania’s pharmaceutical market. Over these five decades, thorough changes in the political regime, subsequent regulatory changes, the emergence of new institutions, and many other factors have drastically changed…

Cegedim Romania To start off, we see that you have been with Cegedim Romania for 10 years, after running your own business initially. What would you say have been your main milestones and achievements since you have joined? Having been with a local and regional company at first, it has been quite…

Commerce and Business Environment of Romania Within a broad assessment of Romania’s investment climate, there is no doubt that every country has some key factors upon which can be capitalized to attract foreign investors. In sum, how would you describe the current investment climate in Romania, and what are these factors that the country can leverage…

Novo Nordisk Romania You have become the head of Novo Nordisk’s operations in Romania in March 2008. Can you first give our readers an idea on how the market environment was at that time? With regards to the national program for diabetes, 2007 was a year of big changes. Most importantly, drug medicines…

Eli Lilly Romania S.R.L. You have just arrived as general manager in January 2011. Coming to a new market obviously means a new context, different challenges and so on. Can you first elaborate on your key priorities as you took over? There are at least two levels of priorities when you arrive in a…

Merck Sharp & Dohme (MSD) Romania You have only just arrived from Korea to head the Romanian operations at MSD. Just recently, you told in an interview with Medica Academica that MSD Romania enjoys a good reputation within MSD worldwide. Can you first elaborate to our readers what factors underlie this strong reputation? When I was…